Metastatic Renal Cell Carcinoma versus Pancreatic Neuroendocrine Tumor in von Hippel-Lindau Disease: Treatment with Interleukin-2
Differentiating between clear cell neuroendocrine tumor (NET) of the pancreas and renal cell carcinoma (RCC) metastatic to the pancreas can be challenging in patients with von Hippel-Lindau disease (VHL). The clear cell features of both NET and RCC in VHL patients may lead to misdiagnosis, inaccurat...
Main Authors: | Christopher Williams, McClellan Walther |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2005-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1100/tsw.2005.5 |
Similar Items
-
Implications of Von Hippel-Lindau Syndrome and Renal Cell Carcinoma
by: Kenan Ashouri, et al.
Published: (2015-09-01) -
Tumor neuroendocrino del páncreas en paciente con enfermedad de Von Hippel Lindau Neuroendocrine pancreatic tumor in a patient with Von Hippel Lindau disease
by: Luis Senra Armas, et al.
Published: (2008-06-01) -
Von Hippel-Lindau disease with extramedullary and pancreatic involvement
by: Pantigozo-Rimachi, Andrea, et al.
Published: (2021) -
Von Hippel Lindau disease
by: Khare M, et al.
Published: (1988-01-01) -
Von Hippel-Lindau Disease
by: Hes Frederik J, et al.
Published: (2005-11-01)